| Hans-Günter Meyer-Thompson | Amphetamine
Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report.
Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report.
Palis, H., MacDonald, S., Jun, J. et al.
Harm Reduct J 18, 57 (2021). doi.org/10.1186/s12954-021-00500-9
https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-021-00500-9